Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk

202280 citationsJournal Article

Authors

In patients with multiple myeloma, MRD status at both ASCT + 3 and ASCT + 9 is a powerful predictor of PFS and OS.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 40, Issue 25, pp. 2889-2900

Field-Weighted Citation Impact: 11.23